Adline Chem Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve Unaudited Standalone Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adline Chem Lab Ltd has informed BSE that its Board of Directors will meet on 10th February 2026. The key agenda items are: (1) to consider and approve the Standalone Unaudited Financial Results for the quarter ended 31st December 2025 along with the Limited Review Report, and (2) to appoint Mr. Vrushank Balkrushna Patel (DIN: 05310613), currently a Director of the Company, as the Chairman & Managing Director (change in designation) for a tenure up to 4th March 2029, effective from 10th February 2026. The trading window for designated persons has been closed since 1st January 2026 and will remain closed until 48 hours after the Q3 results announcement.
This is a routine pre-results intimation combined with an internal leadership elevation — an existing Director is being redesignated as Chairman & Managing Director rather than bringing in someone new. Shareholders should watch the Q3 FY26 results on 10th February for actual performance numbers, as the leadership change itself is unlikely to be a stock-moving event.